NCT00063310

Data

{
  "briefSummary": "ALADDIN is a research study to investigate the safety and effectiveness of leuprolide (a hormone drug) to improve the cognitive function and slow the progression of Alzheimer's disease (AD). In women leuprolide is commonly used to treat hormone related conditions such as endometriosis and uterine fibroids. The study will include treatment of women 65 years and older with mild to moderate Alzheimer's disease who reside in the community.",
  "completionDate": "2006-02",
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": 90,
  "enrollmentType": null,
  "nctId": "NCT00063310",
  "phase": "PHASE2",
  "sponsorId": "voyager-pharmaceutical-corporation",
  "startDate": "2003-03",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN)",
  "url": "https://clinicaltrials.gov/study/NCT00063310"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version